{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:31:02Z","timestamp":1793255462425,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R21DK116140"],"award-info":[{"award-number":["R21DK116140"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["T32HG008958"],"award-info":[{"award-number":["T32HG008958"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09296-1","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:42:40Z","timestamp":1751434960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Donor and recipient genetic variants in drug metabolizing enzymes and transporters affect early tacrolimus pharmacokinetics after liver transplantation"],"prefix":"10.1038","volume":"15","author":[{"given":"Alexandra D.","family":"Ladd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Angeli-Pahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyavardhan","family":"Nittu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatinder","family":"Lamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Zarrinpar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"9296_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cpt.113","volume":"98","author":"KA Birdwell","year":"2015","unstructured":"Birdwell, K. A. et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing. Clin. Pharmacol. Ther. 98, 19\u201324. https:\/\/doi.org\/10.1002\/cpt.113 (2015).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"9296_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1472-8206.2007.00504.x","volume":"21","author":"RA Op den Buijsch","year":"2007","unstructured":"Op den Buijsch, R. A. et al. Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms. Fundament. clin. Pharmacol. 21(4), 427\u2013435 (2007).","journal-title":"Fundament. clin. Pharmacol."},{"key":"9296_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020379","author":"G Coste","year":"2022","unstructured":"Coste, G. & Lemaitre, F. The role of intra-patient variability of tacrolimus drug concentrations in solid organ transplantation: A focus on liver, heart, lung and pancreas. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics14020379 (2022).","journal-title":"Pharmaceutics"},{"key":"9296_CR4","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1097\/TP.0000000000002052","volume":"102","author":"M Rayar","year":"2018","unstructured":"Rayar, M. et al. High intrapatient variability of tacrolimus exposure in the early period after liver transplantation is associated with poorer outcomes. Transplantation 102, e108\u2013e114. https:\/\/doi.org\/10.1097\/TP.0000000000002052 (2018).","journal-title":"Transplantation"},{"key":"9296_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001700","volume":"10","author":"S Lattimore","year":"2024","unstructured":"Lattimore, S. et al. Impact of intrapatient immunosuppression variability in liver transplantation outcomes: A systematic review and meta-analysis. Transpl. Direct. 10, e1700. https:\/\/doi.org\/10.1097\/TXD.0000000000001700 (2024).","journal-title":"Transpl. Direct."},{"key":"9296_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/phar.2480","volume":"41","author":"L Schumacher","year":"2021","unstructured":"Schumacher, L., Leino, A. D. & Park, J. M. Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective. Pharmacotherapy 41, 103\u2013118. https:\/\/doi.org\/10.1002\/phar.2480 (2021).","journal-title":"Pharmacotherapy"},{"key":"9296_CR7","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1111\/cts.13276","volume":"15","author":"C Dopazo","year":"2022","unstructured":"Dopazo, C. et al. High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation. Clin. Transl. Sci. 15, 1544\u20131555. https:\/\/doi.org\/10.1111\/cts.13276 (2022).","journal-title":"Clin. Transl. Sci."},{"key":"9296_CR8","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1399-3046.2010.01409.x","volume":"14","author":"SM Pollock-Barziv","year":"2010","unstructured":"Pollock-Barziv, S. M. et al. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children. Pediatr. Transpl. 14, 968\u2013975. https:\/\/doi.org\/10.1111\/j.1399-3046.2010.01409.x (2010).","journal-title":"Pediatr. Transpl."},{"key":"9296_CR9","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1124\/dmd.111.039040","volume":"39","author":"I Laverdi\u00e8re","year":"2011","unstructured":"Laverdi\u00e8re, I., Caron, P., Harvey, M., L\u00e9vesque, \u00c9. & Guillemette, C. In vitro investigation of human UDP-glucuronosyltransferase isoforms responsible for tacrolimus glucuronidation: Predominant contribution of UGT1A4. Drug Metab. Dispos. 39, 1127\u20131130. https:\/\/doi.org\/10.1124\/dmd.111.039040 (2011).","journal-title":"Drug Metab. Dispos."},{"key":"9296_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/01.fpc.0000184953.31324.e4","volume":"16","author":"M Uesugi","year":"2006","unstructured":"Uesugi, M. et al. Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients. Pharmacogenet Genom. 16, 119\u2013127 (2006).","journal-title":"Pharmacogenet Genom."},{"key":"9296_CR11","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3892\/ijmm.2011.794","volume":"28","author":"A Provenzani","year":"2011","unstructured":"Provenzani, A. et al. Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in caucasian liver and kidney transplant patients. Int. J. Mol. Med. 28, 1093\u20131102. https:\/\/doi.org\/10.3892\/ijmm.2011.794 (2011).","journal-title":"Int. J. Mol. Med."},{"key":"9296_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/lt.20709","volume":"12","author":"W Wei-lin","year":"2006","unstructured":"Wei-lin, W. et al. Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients. Liver Transpl. 12, 775\u2013780. https:\/\/doi.org\/10.1002\/lt.20709 (2006).","journal-title":"Liver Transpl."},{"key":"9296_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1432-2277.2012.01446.x","volume":"25","author":"G Gervasini","year":"2012","unstructured":"Gervasini, G. et al. Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation. Transpl. Int. 25, 471\u2013480. https:\/\/doi.org\/10.1111\/j.1432-2277.2012.01446.x (2012).","journal-title":"Transpl. Int."},{"key":"9296_CR14","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1373\/clinchem.2011.165613","volume":"57","author":"L Elens","year":"2011","unstructured":"Elens, L. et al. A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients. Clin. Chem. 57, 1574\u20131583. https:\/\/doi.org\/10.1373\/clinchem.2011.165613 (2011).","journal-title":"Clin. Chem."},{"key":"9296_CR15","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1177\/1060028019897050","volume":"54","author":"J Shao","year":"2020","unstructured":"Shao, J. et al. Impact of donor and recipient. Ann. Pharmacother. 54, 652\u2013661. https:\/\/doi.org\/10.1177\/1060028019897050 (2020).","journal-title":"Ann. Pharmacother."},{"key":"9296_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101752","volume":"55","author":"B Shi","year":"2023","unstructured":"Shi, B. et al. Genotype-guided model significantly improves accuracy of tacrolimus initial dosing after liver transplantation. EClinicalMedicine 55, 101752. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101752 (2023).","journal-title":"EClinicalMedicine"},{"key":"9296_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/01.fpc.0000220571.20961.dd","volume":"16","author":"JN Roy","year":"2006","unstructured":"Roy, J. N., Barama, A., Poirier, C., Vinet, B. & Roger, M. Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients. Pharmacogenet. Genom. 16, 659\u2013665. https:\/\/doi.org\/10.1097\/01.fpc.0000220571.20961.dd (2006).","journal-title":"Pharmacogenet. Genom."},{"key":"9296_CR18","doi-asserted-by":"publisher","first-page":"333ra349","DOI":"10.1126\/scitranslmed.aac5954","volume":"8","author":"A Zarrinpar","year":"2016","unstructured":"Zarrinpar, A. et al. Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform. Sci. Transl. Med. 8, 333ra349. https:\/\/doi.org\/10.1126\/scitranslmed.aac5954 (2016).","journal-title":"Sci. Transl. Med."},{"key":"9296_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbrc.2005.09.020","volume":"338","author":"C Rodr\u00edguez-Antona","year":"2005","unstructured":"Rodr\u00edguez-Antona, C., Sayi, J. G., Gustafsson, L. L., Bertilsson, L. & Ingelman-Sundberg, M. Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles. Biochem. Biophys. Res. Commun. 338, 299\u2013305. https:\/\/doi.org\/10.1016\/j.bbrc.2005.09.020 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9296_CR20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1097\/TP.0b013e31819f117e","volume":"87","author":"KR Jun","year":"2009","unstructured":"Jun, K. R. et al. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea. Transplantation 87, 1225\u20131231. https:\/\/doi.org\/10.1097\/TP.0b013e31819f117e (2009).","journal-title":"Transplantation"},{"key":"9296_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1124\/dmd.104.002576","volume":"33","author":"A Mori","year":"2005","unstructured":"Mori, A., Maruo, Y., Iwai, M., Sato, H. & Takeuchi, Y. UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation. Drug Metab. Dispos. 33, 672\u2013675. https:\/\/doi.org\/10.1124\/dmd.104.002576 (2005).","journal-title":"Drug Metab. Dispos."},{"key":"9296_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.phrs.2017.03.027","volume":"124","author":"C Tron","year":"2017","unstructured":"Tron, C. et al. Tacrolimus: Does direct glucuronidation matter? an analytical and pharmacological perspective. Pharmacol. Res. 124, 164\u2013166. https:\/\/doi.org\/10.1016\/j.phrs.2017.03.027 (2017).","journal-title":"Pharmacol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09296-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09296-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09296-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:42:41Z","timestamp":1751434961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09296-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9296"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09296-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23508"}}